StockData
Alector, Inc. logo

Alector, Inc. (ALEC) stock

ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$2.57+0.01 (+0.39%)

Close on Nov 18, 2026Market cap $286.96MP/E –Yield –

Alector operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Alector's operating income for the twelve months ending Jun 30, 2026 was -$126.49M. For fiscal 2025 it was -$156.01M. The highest annual figure on record is -$32.68M in fiscal 2017.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$156.01M–
FY2024Dec 31, 2024-$145.00M–
FY2023Dec 31, 2023-$151.74M–
FY2022Dec 31, 2022-$137.83M–
FY2021Dec 31, 2021-$37.36M–
FY2020Dec 31, 2020-$195.17M–
FY2019Dec 31, 2019-$114.40M–
FY2018Dec 31, 2018-$57.29M–
FY2017Dec 31, 2017-$32.68M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$24.39M–
Q1 FY2026Mar 31, 2026-$24.92M–
Q4 FY2025Dec 31, 2025-$39.57M–
Q3 FY2025Sep 30, 2025-$37.61M–
Q2 FY2025Jun 30, 2025-$34.14M–
Q1 FY2025Mar 31, 2025-$44.70M–
Q4 FY2024Dec 31, 2024-$7.25M–
Q3 FY2024Sep 30, 2024-$48.43M–
Q2 FY2024Jun 30, 2024-$45.61M–
Q1 FY2024Mar 31, 2024-$43.71M–
Q4 FY2023Dec 31, 2023-$47.45M–
Q3 FY2023Sep 30, 2023-$50.58M–
Q2 FY2023Jun 30, 2023-$3.59M-137.9%
Q1 FY2023Mar 31, 2023-$50.12M–
Q4 FY2022Dec 31, 2022-$55.44M–
Q3 FY2022Sep 30, 2022-$47.75M-137.8%
Q2 FY2022Jun 30, 2022$9.48M–
Q1 FY2022Mar 31, 2022-$44.12M–
Q4 FY2021Dec 31, 2021-$55.73M–
Q3 FY2021Sep 30, 2021$126.33M–
Q2 FY2021Jun 30, 2021-$55.33M–
Q1 FY2021Mar 31, 2021-$52.64M–
Q4 FY2020Dec 31, 2020-$52.76M–
Q3 FY2020Sep 30, 2020-$53.75M–
Q2 FY2020Jun 30, 2020-$46.59M–
Q1 FY2020Mar 31, 2020-$42.08M–
Q4 FY2019Dec 31, 2019-$32.34M–
Q3 FY2019Sep 30, 2019-$34.15M–
Q2 FY2019Jun 30, 2019-$27.15M–
Q1 FY2019Mar 31, 2019-$20.76M–
Q4 FY2018Dec 31, 2018-$19.02M–
Q3 FY2018Sep 30, 2018-$16.82M–
Q2 FY2018Jun 30, 2018-$12.23M–
Q1 FY2018Mar 31, 2018-$9.23M–

More Alector figures

See a number that looks wrong?